Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Knee Bursitis Market CAGR Outlook And Future Development
The knee bursitis market has experienced significant expansion in recent years. This market is set to expand from $2.86 billion in 2025 to $3.06 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. The factors contributing to its past growth include the rising prevalence of knee injuries and repetitive stress conditions, increased involvement in sports and physical activities, the well-established application of imaging in musculoskeletal diagnostics, a burgeoning elderly population with joint disorders, and the ready availability of anti-inflammatory drugs.
The knee bursitis market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $3.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the forecast period include the increasing demand for minimally invasive treatment options, a heightened emphasis on early diagnosis and preventive measures, the growing acceptance of physiotherapy services, the development of orthopedic care facilities, and enhanced availability of diagnostic imaging in developing regions. Key trends anticipated within this period involve a rising preference for non-surgical approaches to knee bursitis management, greater utilization of imaging techniques for precise diagnosis, an uptick in the adoption of physical therapy and rehabilitation, the broadening of outpatient and conservative treatment methods, and enhanced patient understanding of early knee injury care.
Get A Free Sample Report With In-Depth Market Insights:
Knee Bursitis Market Demand Drivers: What’s Powering Industry Growth?
The growing occurrence of bone-related conditions is anticipated to fuel the expansion of the knee bursitis market moving forward. Bone disorders encompass ailments such as osteoporosis, arthritis, and bone cancer, impacting the skeletal system’s structure, strength, and function. The increased prevalence of these conditions is attributed to factors like an aging population, inactive lifestyles, inadequate nutrition, and environmental shifts. Bone-related diseases, including osteoarthritis and rheumatoid arthritis, can contribute to knee bursitis by causing inflammation and excessive pressure on the knee bursa. This inflammation leads to pain, swelling, and diminished joint movement. For example, in October 2024, Healthy Bones Australia, a national nonprofit organization based in Australia dedicated to osteoporosis prevention and bone health awareness, reported that an estimated 6.2 million Australians aged 50 and above, representing about 67% of this age group, were living with poor bone health. This figure is projected to climb significantly, reaching approximately 7.7 million individuals with osteopenia or osteoporosis by 2033. Consequently, the rising prevalence of bone-related diseases is driving the growth of the knee bursitis market.
Knee Bursitis Market Segment Analysis And Revenue Potential
The knee bursitis market covered in this report is segmented –
1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users
Subsegments:
1) By Clinical Evaluation: Medical History Assessment, Physical Examination
2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging
3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests
4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment
Knee Bursitis Market Key Players Shaping Industry Direction
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.
View The Full Knee Bursitis Market Report:
Knee Bursitis Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
